The development of vaccines can be divided into stages, from discovery to implementation. The TB Vaccine Development Pathway proposes an assessment process to track progress and make decisions on the advancement of a tuberculosis vaccine candidate to its next stage of development.
The TB Vaccine Development Pathway was established by a team of scientific and technical experts from TBVI and IAVI with the input of the TB vaccine community. The tool has been developed on behalf of the Global TB Vaccine Partnership (GTBVP), an alliance of organisations that aim at making novel TB vaccines a reality, and is funded by the Bill & Melinda Gates Foundation.
